Literature DB >> 16341860

SNEP: SNP-derived epitope prediction program for minor H antigens.

Mathias M Schuler1, Pierre Dönnes, Maria-Dorothea Nastke, Oliver Kohlbacher, Hans-Georg Rammensee, Stefan Stevanovic.   

Abstract

The single nucleotide polymorphism (SNP)-derived Epitope Prediction program (SNEP) is now available to the public. It predicts minor histocompatibility antigens (miHAgs), which are T-cell epitopes containing polymorphic spots, from proteins listed in the SWISS-PROT database. SNEP recognizes polymorphisms (termed VARIANT or CONFLICT in SWISS-PROT) and predicts potential T-cell epitopes within a chosen distance around the polymorphic residue. The prediction algorithm is based on the SYFPEITHI T-cell epitope prediction program. SNEP is able to search for proteins according to their accession numbers, sequence stretches or gene names, for example. The predictions are available for several human leucocyte antigen class I and class II allelic products, which allow for a rapid and precise evaluation of potential miHAgs within polymorphic antigens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341860     DOI: 10.1007/s00251-005-0054-5

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  12 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  ExPASy: The proteomics server for in-depth protein knowledge and analysis.

Authors:  Elisabeth Gasteiger; Alexandre Gattiker; Christine Hoogland; Ivan Ivanyi; Ron D Appel; Amos Bairoch
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 3.  Update on graft versus host disease.

Authors:  Anita C Gilliam
Journal:  J Invest Dermatol       Date:  2004-08       Impact factor: 8.551

4.  Identification of classical minor histocompatibility antigen as cell-derived peptide.

Authors:  H J Wallny; H G Rammensee
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

5.  Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.

Authors:  H J Kolb; J Mittermüller; C Clemm; E Holler; G Ledderose; G Brehm; M Heim; W Wilmanns
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

6.  The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

Authors:  Mario H J Vogt; Joost W van den Muijsenberg; Els Goulmy; Eric Spierings; Petra Kluck; Michel G Kester; Ronald A van Soest; Jan W Drijfhout; Roel Willemze; J H Frederik Falkenburg
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

Review 7.  Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy.

Authors:  Els Goulmy
Journal:  Cancer J       Date:  2004 Jan-Feb       Impact factor: 3.360

8.  Hematopoietic lineage-restricted minor histocompatibility antigen HA-1 in graft-versus-leukemia activity after donor lymphocyte infusion.

Authors:  Brigitte Kircher; Maria Wolf; Stefan Stevanovic; Hans-Georg Rammensee; Beatrix Grubeck-Loebenstein; Günther Gastl; David Nachbaur
Journal:  J Immunother       Date:  2004 Mar-Apr       Impact factor: 4.456

9.  The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing.

Authors:  A G Brickner; E H Warren; J A Caldwell; Y Akatsuka; T N Golovina; A L Zarling; J Shabanowitz; L C Eisenlohr; D F Hunt; V H Engelhard; S R Riddell
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

10.  Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens.

Authors:  Yoshiki Akatsuka; Tetsuya Nishida; Eisei Kondo; Mikinori Miyazaki; Hirohumi Taji; Hiroatsu Iida; Kunio Tsujimura; Makoto Yazaki; Tomoki Naoe; Yasuo Morishima; Yoshihisa Kodera; Kiyotaka Kuzushima; Toshitada Takahashi
Journal:  J Exp Med       Date:  2003-05-27       Impact factor: 14.307

View more
  6 in total

Review 1.  Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation.

Authors:  Jenny Zilberberg; Rena Feinman; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2014-11-20       Impact factor: 5.742

Review 2.  Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms.

Authors:  Anthony G Brickner
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses.

Authors:  Xin Feng; Kwok Min Hui; Hashem M Younes; Anthony G Brickner
Journal:  Trends Immunol       Date:  2008-10-25       Impact factor: 16.687

4.  SVMHC: a server for prediction of MHC-binding peptides.

Authors:  Pierre Dönnes; Oliver Kohlbacher
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

5.  EpiToolKit--a web-based workbench for vaccine design.

Authors:  Benjamin Schubert; Hans-Philipp Brachvogel; Christopher Jürges; Oliver Kohlbacher
Journal:  Bioinformatics       Date:  2015-02-20       Impact factor: 6.937

6.  EpiToolKit--a web server for computational immunomics.

Authors:  Magdalena Feldhahn; Philipp Thiel; Mathias M Schuler; Nina Hillen; Stefan Stevanovic; Hans-Georg Rammensee; Oliver Kohlbacher
Journal:  Nucleic Acids Res       Date:  2008-04-24       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.